LIFE:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund Hedged Units (CAD)

ETF | Sector Equity |

Last Closing

CAD 20.38

Change

0.00 (0.00)%

Market Cap

CAD 0.22B

Volume

8.08K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-16 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.12 (-0.28%)

CAD 3.37B
ZWU:CA BMO Covered Call Utilities ETF

+0.06 (+0.50%)

CAD 1.79B
XIT:CA iShares S&P/TSX Capped Informa..

+0.21 (+0.32%)

CAD 0.82B
HTA:CA Harvest Tech Achievers Growth ..

+0.13 (+0.76%)

CAD 0.63B
TXF:CA First Asset Tech Giants Covere..

+0.22 (+1.11%)

CAD 0.61B
XHC:CA iShares Global Healthcare (CAD..

+0.98 (+1.44%)

CAD 0.57B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.13 (+0.58%)

CAD 0.51B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.17 (+0.60%)

CAD 0.37B
CWW:CA iShares Global Water Common Cl..

-0.05 (-0.08%)

CAD 0.30B
HUTL:CA Harvest Equal Weight Global Ut..

+0.10 (+0.55%)

CAD 0.27B

ETFs Containing LIFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.82% 91% A- 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.82% 89% A- 83% B
Trailing 12 Months  
Capital Gain -6.30% 20% F 17% F
Dividend Return 2.94% 63% D 48% F
Total Return -3.36% 17% F 17% F
Trailing 5 Years  
Capital Gain 10.22% 17% F 30% F
Dividend Return 40.32% 76% C+ 79% B-
Total Return 50.54% 29% F 36% F
Average Annual (5 Year Horizon)  
Capital Gain 0.63% 23% F 32% F
Dividend Return 1.82% 9% A- 29% F
Total Return 1.20% 53% F 43% F
Risk Return Profile  
Volatility (Standard Deviation) 6.97% 97% N/A 85% B
Risk Adjusted Return 26.18% 20% F 39% F
Market Capitalization 0.22B 65% D 47% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.